Literature DB >> 15019238

An internal element of the measles virus antigenome promoter modulates replication efficiency.

Pramila Walpita1.   

Abstract

The cis-acting sequence elements that direct measles virus (MV) genome synthesis reside in the 109 base non-coding region at the 5' trailer (3' antigenomic) end of MV genome that makes up the antigenomic promoter (AGP). The MV-AGP nucleotides 79-96, corresponding to nucleotide hexamers 14, 15 and 16 (the C' element), show sequence similarity with the equivalent region of many paramyxoviruses and are analogous to the three nucleotide hexamers that form the second replication control element in the Sendai virus AGP. In this study, results of two independent procedures demonstrate that the MV C' element also is a replication control sequence. Results of in vivo nucleotide selection experiments show that selection pressure for retaining the wild type nucleotides at the first position of each of the three hexamers, and for the fifth position of the 14th hexamer was relatively high. However, with continued replication, preference for the conservation of wild type nucleotides across the entire C' element was clearly evident. Results of mutational analysis of individual nucleotides in one or more hexamers in a measles-helper-virus driven reporter gene rescue system agreed with these results. Substitutions at the first position of the 14th, the 15th or the 16th hexamers reduced minireplicon activity dramatically. In contrast, changes at the other five positions of any one hexamer had little or no effect on minireplicon activity, even when all the five bases were changed at the same time. However, when minireplicons were analyzed which contained point mutations at equivalent positions in all three hexamers, it was evident that the nucleotides, particularly those at the 5th position, were also important components of the C' element. This pattern of sequence requirement in the C' element based on mutational analysis could be described as a distinct motif, 5'-(GNNNAN)2GNNNCN-3', that is important for MV replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019238     DOI: 10.1016/j.virusres.2003.12.025

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  11 in total

1.  Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography.

Authors:  Tanmay A M Bharat; Takeshi Noda; James D Riches; Verena Kraehling; Larissa Kolesnikova; Stephan Becker; Yoshihiro Kawaoka; John A G Briggs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

2.  Analysis of nucleotides 13-96 of the human parainfluenza virus type 3 antigenomic promoter reveals positive- and negative-acting replication elements.

Authors:  Jill R Gander; LeeAnne M Schwan; Michael A Hoffman
Journal:  Virology       Date:  2011-08-30       Impact factor: 3.616

Review 3.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

Review 4.  Initiation and regulation of paramyxovirus transcription and replication.

Authors:  Sarah L Noton; Rachel Fearns
Journal:  Virology       Date:  2015-02-13       Impact factor: 3.616

5.  The Ebola virus genomic replication promoter is bipartite and follows the rule of six.

Authors:  Michael Weik; Sven Enterlein; Kathrin Schlenz; Elke Mühlberger
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Roles of human parainfluenza virus type 3 bases 13 to 78 in replication and transcription: identification of an additional replication promoter element and evidence for internal transcription initiation.

Authors:  Michael A Hoffman; LeeAnne M Thorson; John E Vickman; Joseph S Anderson; Nathan A May; Michelle N Schweitzer
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.

Authors:  Linda J Rennick; Rory D de Vries; Thomas J Carsillo; Ken Lemon; Geert van Amerongen; Martin Ludlow; D Tien Nguyen; Selma Yüksel; R Joyce Verburgh; Paula Haddock; Stephen McQuaid; W Paul Duprex; Rik L de Swart
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

8.  The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus.

Authors:  Sven Enterlein; Kristina M Schmidt; Michael Schümann; Dominik Conrad; Verena Krähling; Judith Olejnik; Elke Mühlberger
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

9.  Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells.

Authors:  Tanmay A M Bharat; James D Riches; Larissa Kolesnikova; Sonja Welsch; Verena Krähling; Norman Davey; Marie-Laure Parsy; Stephan Becker; John A G Briggs
Journal:  PLoS Biol       Date:  2011-11-15       Impact factor: 8.029

Review 10.  Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex.

Authors:  Julien Sourimant; Richard K Plemper
Journal:  Viruses       Date:  2016-09-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.